Cannabis Operators Stuck in 280E Limbo as Rescheduling Guidance Lags
Marijuana Moment reported that state-licensed businesses still lack federal tax clarity, leaving 280E liability unresolved while rescheduling guidance remains pending.

Flat lay image featuring a calculator, pens, and a folder labeled 'TAXES', perfect for finance-related themes.
The uncertainty is the tax bill nobody can book
Until federal guidance lands, cannabis operators can't say with confidence what they will owe under Section 280E. That's the core of Marijuana Moment's Oct. 31 report on tax uncertainty during the federal rescheduling wait.
My read: the limbo itself is now a cost. Operators can't plan capital spending, set reserves or price products against a tax rate that might change.
What the report establishes, and what it leaves open
Marijuana Moment framed the problem as businesses waiting on federal guidance, not as a settled change in tax law. The signal we reviewed supplies that framing and little else, so we're not attributing specific figures, quotes or agency statements to it.
That matters. Anyone telling operators the 280E burden is already gone is ahead of the record.
How 280E turns a scheduling decision into a P&L event
Section 280E of the Internal Revenue Code denies deductions and credits to any trade or business trafficking in Schedule I or II controlled substances. Congress enacted it in 1982, and marijuana's Schedule I status has pulled licensed cannabis companies into it ever since.
Moving marijuana to Schedule III would take it outside the statute's text, because 280E doesn't reach Schedule III substances. Cost of goods sold has remained available to cannabis operators all along, but rent, payroll for non-production staff and marketing generally haven't been deductible. For a dispensary with thin margins, that gap can turn an operating profit into a taxable one. The math is brutal.
The effective date matters more than the headline
A rescheduling decision helps only from the date it takes legal effect, and nothing in the signal suggests relief for earlier tax years. 280E applies to the year in which the business trafficks, so a final rule's effective date will decide which returns it touches.
Operators asking about refunds or amended returns should treat that as an open question for tax counsel and, possibly, IRS guidance. Don't spend money you haven't been told you'll get.
Not yet.
Why this sorts MSOs from everyone else
Well-capitalized multistate operators can carry tax uncertainty longer than single-state independents, and that gap widens the longer guidance takes. An MSO with in-house tax staff can model several scenarios and hold reserves against uncertain positions, all while it keeps funding expansion. A two-store operator in California or Colorado often can't. Same wait, different runway.
This is analysis, not reporting from the signal. But the logic is hard to argue with: delay favors the balance sheet. If relief eventually arrives, the biggest operators will be positioned to capture it first, while smaller competitors spend the interim paying full 280E rates.
What operators should be modeling now
The prudent approach is to run at least two tax cases and avoid booking relief that hasn't been granted. One case should assume 280E continues unchanged through the next filing cycle, and the other should assume a Schedule III effective date at some point in the future, with the cash impact separated by tax year.
Operators also have reasons to tighten cost allocation between production and non-production activities now, since cost of goods sold is the deduction that has held up. Lenders and investors will want to see both cases, and a company that shows only the optimistic one will lose credibility with them. Plan for both. The boring work wins here.
Where the DEA path stands
The federal process traces to an HHS recommendation in August 2023 and a DEA proposed rule published in May 2024. Those two steps set the Schedule III track, but they didn't end it. A final rule, and the date it takes effect, still determines whether 280E relief becomes real.
For full background on this story, see the CannIntel topic hub on DEA rescheduling. The IRS would also have to decide how it treats the transition for businesses that spent years under 280E, and the signal doesn't say whether any such guidance is coming.
The next signal to watch is whether a final DEA rule appears with a stated effective date, followed by any IRS statement on how 280E applies to the transition period. Until both exist, treat every projected tax savings as a forecast, not a receivable.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What is Section 280E?
Section 280E of the Internal Revenue Code, enacted in 1982, denies business deductions and credits to any trade or business trafficking in Schedule I or II controlled substances. Because marijuana is Schedule I, licensed cannabis companies generally can't deduct ordinary expenses, though cost of goods sold remains available.
Would Schedule III eliminate 280E for cannabis businesses?
By its text, 280E applies only to Schedule I and II substances, so a marijuana move to Schedule III would take it outside the statute going forward. Timing depends on a final rule's effective date, and the signal doesn't address relief for past tax years.
Can cannabis operators claim refunds if rescheduling happens?
The signal doesn't say. 280E applies by tax year, so relief likely depends on the rule's effective date and any IRS guidance. Operators should consult tax counsel before booking refunds or amending returns.
Why does rescheduling uncertainty hurt smaller operators more?
Larger multistate operators generally have in-house tax teams and balance sheets to model scenarios and hold reserves. Smaller independents often can't, so prolonged delay means paying full 280E rates without the cushion to plan around possible relief.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

stupidDOPE Pairs $28.4B Cannabis Tax Figure With No-Arrests Claim
A headline cites $28.4 billion in cannabis taxes with zero arrests required, but the period, jurisdictions and tax types are unspecified. Here is how to read it.

Missouri Marijuana Operators Still Await IRS Guidance After Rescheduling
Six months after federal officials eased medical marijuana's classification, Missouri businesses say the tax relief they expected still depends on IRS direction that hasn't arrived.

Missouri Marijuana Operators Await IRS Rules on Tax Relief
Missouri cannabis businesses are still waiting on written IRS guidance for promised federal tax relief, leaving 280E-era accounting and software setups unchanged.
More from the newsroom

Study Finds CBC-Derived Compounds Trigger Prostate Cancer Cell Death
A study reported Oct. 31 says compounds derived from cannabichromene killed prostate cancer cells, but the data is preclinical and the details are thin.

Review Finds CBD May Shield Brain From Meth Injury, Trials Absent
A review reported Oct. 31 says cannabidiol may protect against methamphetamine-related brain damage through several pathways, but no human trial data is cited in the report.

University of Florida Study Finds 81% Cut Opioids With Medical Cannabis
A University of Florida study reports 94% of chronic pain patients saw relief and 81% reduced or stopped opioids, though key methodology details remain unreported.